Insys Therapeutics (INSY) call put ratio 6.5 calls to 1 put into Q4
Insys Therapeutics (NASDAQ: INSY) Insys Therapeutics (NASDAQ: INSY) March call option implied volatility is at 91, April is at 87; compared to its 52-week range of 54 to 143 into the expected release of Q4 results on March 8.